Photo of Anne Marie McCarthy,  PhD

Anne Marie McCarthy, PhD

Massachusetts General Hospital

Massachusetts General Hospital


amccarthy8@partners.org

Anne Marie McCarthy, PhD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Assistant Professor, Medicine, Harvard Medical School
  • Assistant in Epidemiology, Medicine, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

As a cancer epidemiologist, my career goal is to reduce the burden of breast cancer through improved prevention and screening strategies. Specifically my research aims to build an evidence base to inform precision medicine approaches to breast cancer prevention and early detection, particularly for racial/ethnic minorities.

Publications

Powered by Harvard Catalyst
  • Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin 2018. PubMed
  • Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B. Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol 2018. PubMed
  • Bahl M, Gaffney S, McCarthy AM, Lowry KP, Dang PA, Lehman CD. Breast Cancer Characteristics Associated with 2D Digital Mammography versus Digital Breast Tomosynthesis for Screening-detected and Interval Cancers. Radiology 2017. PubMed
  • Dean LT, Moss SL, McCarthy AM, Armstrong K. Healthcare System Distrust, Physician Trust, and Patient Discordance with Adjuvant Breast Cancer Treatment Recommendations. Cancer Epidemiol Biomarkers Prev 2017. PubMed
  • McDonald ES, McCarthy AM, Weinstein SP, Schnall MD, Conant EF. BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis. Radiology 2017. PubMed
  • Jones T, McCarthy AM, Kim Y, Armstrong K. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study. Cancer Med 2017. PubMed
  • Kim Y, McCarthy AM, Bristol M, Armstrong K. Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer. NPJ Breast Cancer 2017; 3:2. PubMed
  • Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, Barlow WE. Breast cancer screening initiation after turning 40¬†years of age within the PROSPR consortium. Breast Cancer Res Treat 2016. PubMed
  • Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, Tosteson AN, McCarthy AM, Poplack SP, Haas JS, Armstrong K, Schnall MD, Barlow WE. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat 2016; 156:109-16. PubMed
  • Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, Rutter CM, Tosteson TD, Trentham-Dietz A, Weaver DL, . Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med 2015. PubMed
  • McDonald ES, McCarthy AM, Akhtar AL, Synnestvedt MB, Schnall M, Conant EF. Baseline Screening Mammography: Performance of Full-Field Digital Mammography Versus Digital Breast Tomosynthesis. AJR Am J Roentgenol 2015; 205:1143-8. PubMed
  • McCarthy AM, Yamartino P, Yang J, Bristol M, Conant EF, Armstrong K. Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST). Med Care 2015; 53:673-8. PubMed
  • McCarthy AM, Yang J, Armstrong K. Increasing disparities in breast cancer mortality from 1979 to 2010 for US black women aged 20 to 49 years. Am J Public Health 2015; 105 Suppl 3:S446-8. PubMed
  • Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Womens Health (Larchmt) 2015; 24:138-43. PubMed
  • Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D. Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography. BMC Cancer 2015; 15:143. PubMed
  • McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms. Breast Cancer Res 2015; 17:1. PubMed
  • McCarthy AM, Kontos D, Synnestvedt M, Tan KS, Heitjan DF, Schnall M, Conant EF. Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. Journal of the National Cancer Institute 2014. PubMed
  • McCarthy AM, Armstrong K. The role of testing for BRCA1 and BRCA2 mutations in cancer prevention. JAMA Intern Med 2014; 174:1023-4. PubMed
  • McCarthy AM, Bristol M, Fredricks T, Wilkins L, Roelfsema I, Liao K, Shea JA, Groeneveld P, Domchek SM, Armstrong K. Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer 2013; 119:3596-603. PubMed
  • McCarthy AM, McGuire E, Bristol M, Fredricks T, Domchek SM, Armstrong K. Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients. 2013; 37:601-5. PubMed
  • Vig HS, McCarthy AM, Liao K, Demeter MB, Fredericks T, Armstrong K. Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients. Cancer Epidemiol Biomarkers Prev 2013; 22:1778-85. PubMed
  • McCarthy AM, Menke A, Visvanathan K. Association of bilateral oophorectomy and body fatness in a representative sample of US women. Gynecol Oncol 2013; 129:559-64. PubMed
  • McCarthy AM, Armstrong K, Handorf E, Boghossian L, Jones M, Chen J, Demeter MB, McGuire E, Conant EF, Domchek SM. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women. Breast Cancer Res Treat 2013; 138:889-98. PubMed
  • McCarthy AM, Menke A, Ouyang P, Visvanathan K. Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older. Cancer Prev Res (Phila Pa) 2012; 5:847-54. PubMed
  • McCarthy AM, Dumanovsky T, Visvanathan K, Kahn AR, Schymura MJ. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes Control 2010; 21:1645-55. PubMed
  • McCarthy AM, Visvanathan K. Breast cancer prognosis: weighing the evidence on weight and physical activity. Oncology (Huntingt) 2010; 24:346-7, 350. PubMed
Hide